Simultaneously, these c-Met inhibitors effectively inhibited proliferation of the tumor cells by a pronounced G2/M cell cycle arrest and confirmed previous findings in foretinib-treated SK-OV-3 cells [35]. The gene discussed is MET; the disease is neoplasm.